Doctors Discourage Unregulated Use of Testosterone Treatment Drugs in Wake of Mounting Testosterone Lawsuits, Reports Wright & Schulte LLC
With men over 40 wanting testosterone medication to give them more energy, increase their sex drive and manage depression, doctors are warning that testosterone replacement therapy may not help all men combat the symptoms of what some call “male menopause.” or “Low T”. Fox News reported. The report further purported that while men are taking the testosterone medication either by prescription or ordering it off the Internet without talking to a doctor first and getting prescription, medical experts are debating over whether the phase of life men experience in their 40s and 50s should be treated at all by medication. There are currently more than 50 testosterone lawsuits pending in U.S. District Court, Eastern District of Louisiana. (In Re: Testosterone Products Liability Litigation, No. 42, JPML), and in in the U.S. District Court, Northern District of Illinois (In Re: AndroGel Product Liability Litigation, MDL Docket No. 36).
The attorneys at Wright & Schulte continue to speak with men who believe they have suffered heart attacks, strokes, or other cardiac events due to testosterone treatment drugs like AndroGel, Androderm and Testim. Free testosterone lawsuit evaluations are available by calling 1-800-399-0795 or you can visit yourlegalhelp.com.
Wright & Schulte has further learned from Fox News that some doctors warn that testosterone therapy is not for all men because of the alleged dangers of the prescription medication which studies have linked to an increase in heart attack in older men. Still, other medical experts contend that it doesn’t make sense not to take testosterone replacement treatment if a man’s quality of life is at stake. A urologist at the University of Colorado Hospital stated in the Fox News 31 report that the key is for doctors to tailor testosterone therapy to each patient’s medical history while weighing the risks to the benefits.
[kdvr.com/2014/05/08/doctors-caution-treatments-for-low-testosterone-in-men/, May 12, 2014]
Testosterone replacement therapy is used to treat hypogonadism (low testosterone), in men who suffer from low testosterone due to an underlying medical condition or injury. Court records indicate that lawsuits regarding testosterone replacement therapy have increased since the U.S. Food & Drug Administration (FDA) announced in January 2014 that it was re-evaluating low testosterone treatment medication and their potential risk of causing heart attacks and strokes. The FDA based its decision on two studies concerning testosterone drugs. In one study, published in November 2013 by Journal of the American Medical Association suggested that older men with underlying cardiovascular disease who used prescription testosterone medication had an increased risk of heart attack. In the second study cited by the FDA, older men and younger men with a history of heart disease who used prescribed testosterone medication had an increased risk of heart attack.
[fda.gov/Drugs/DrugSafety/ucm383904.htm, January 31, 2014]
According to court documents, more than 50 testosterone lawsuits are currently pending in courts across the country. So much so that a motion was filed with the U.S. Judicial Panel of Multidistrict Litigation (JPML) to transfer all federal testosterone replacement therapy complaints to the U.S. District Court, Eastern District of Louisiana for consolidated pretrial. Plaintiffs in the more than 50 testosterone treatment lawsuits allege that prescription therapy drugs causes heart attacks, strokes and other life-threatening side-effects (In Re: Testosterone Products Liability Litigation, No. 42, JPML). The drugs listed in the testosterone complaints include:
A similar motion was filed regarding 30 AndroGel testosterone lawsuits against Abbot Laboratories Inc. and AbbVie, Inc., the manufacturers of AndroGel. The plaintiffs in the AndroGel complaints allege that they experienced heart attacks, strokes and other cardiovascular problems after using the prescribed medication and contend that the defendants did not adequately warn consumers and health care providers about the serious health risks associated with using the products. The plaintiffs asked the JPML to transfer all AndroGel complaints to the U.S. District Court, Northern District of Illinois. (In Re: AndroGel Product Liability Litigation, MDL Docket No. 36) The JPML is scheduled to hear oral arguments on May 29, 2014 in Chicago on the AndroGel motion.
About Wright & Schulte LLC
Wright & Schulte LLC is offering free, no-obligation AndroGel testosterone lawsuit evaluations to individuals who suffered serious and life-threatening cardiovascular events that may be associated with their use of AndroGel. For more information or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.